Skip to main content
. Author manuscript; available in PMC: 2019 Nov 14.
Published in final edited form as: Oral Oncol. 2019 Mar 4;91:69–78. doi: 10.1016/j.oraloncology.2019.02.026

Table 5.

Descriptive statistics of marker expression, NCI-8070.

Marker Treatment Arm N Minimum 1st Tertile Median 2nd Tertile Maximum
PTEN Cetuximab 16 481.0 1568.4 2237.5 2857.4 5307.1
Cetuximab + Sorafenib 21 441.7 851.8 1293.0 2091.5 6263.3
Total 37 441.7 1177.3 1568.4 2385.9 6263.3
PI3 p110 Cetuximab 16 311.4 882.1 986.5 1206.1 3101.4
Cetuximab + Sorafenib 21 370.6 790.2 853.6 1049.3 2777.1
Total 37 311.4 801.0 882.1 1142.8 3101.4